Search
for
Sort by
Research 121–150 of 334
- Risk of autoimmune diseases in patients with RASopathies: systematic study of humoral and cellular immunity
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Effect of Sun exposure-induced ferroptosis mechanisms on pathology and potential biological processes of primary melanoma by microarray data analysis
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Targeting the (Un)differentiated State of Cancer
- FilaggrinHigh melanomas exhibit active FGFR and allergic signatures with impaired GNA14 and Th1 signatures
- Re‐Innovation in Clinical Trial Designs Based on Precision Therapy
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Oncogenic senescence: a multi-functional perspective
- Epigenetics of Colorectal Cancer
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
- Comparison between low-dose chemotherapy and surgery for the treatment of extremity-associated solitary bone lesions in children with Langerhans cell histiocytosis in South China: A case-control study
- Dermatologic Adverse Events from Cancer Treatments
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Expression patterns of MITF during human cutaneous embryogenesis: evidence for bulge epithelial expression and persistence of dermal melanoblasts
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- Aged Skin Cells Nurture Stem Cells toward Regeneration
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Gray Hair: From Preventive to Treatment
- The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression
- NEDD4 and NEDD4L regulate Wnt signalling and intestinal stem cell priming by degrading LGR5 receptor
- Discrimination of Dysplastic Nevi from Common Melanocytic Nevi by Cellular and Molecular Criteria
- Keratin intermediate filaments in the colon: guardians of epithelial homeostasis
- The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Autophagy: Guardian of Skin Barrier
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Hedgehog Signaling in Papillary Fibroblasts Is Essential for Hair Follicle Regeneration during Wound Healing